Dong, L., Cao, Z., Chen, M., Liu, Y., Ma, X., Lu, Y., . . . Han, W. (2024). Inhibition of glycosphingolipid synthesis with eliglustat in combination with immune checkpoint inhibitors in advanced cancers. Nature Communications, 15(1), 1. https://doi.org/10.1038/s41467-024-51495-3
Chicago-referens (17:e uppl.)Dong, Liang, et al. "Inhibition of Glycosphingolipid Synthesis with Eliglustat in Combination with Immune Checkpoint Inhibitors in Advanced Cancers." Nature Communications 15, no. 1 (2024): 1. https://doi.org/10.1038/s41467-024-51495-3.
MLA-referens (9:e uppl.)Dong, Liang, et al. "Inhibition of Glycosphingolipid Synthesis with Eliglustat in Combination with Immune Checkpoint Inhibitors in Advanced Cancers." Nature Communications, vol. 15, no. 1, 2024, p. 1, https://doi.org/10.1038/s41467-024-51495-3.
